They’re actually doing it!
San Francisco about to deploy 200 shots of ACAM2000, a LIVE cowpox vaccine into population to fight monkeypox.
“There is also a risk that people who receive ACAM2000 could accidentally spread the cowpox virus from the vaccine to close contacts who are unvaccinated,” Sanchez stated. “Special training and equipment are also required to administer the vaccine safely and effectively. Due to these limitations and challenges, the Jynneos vaccine, while in short supply, is considered safer and preferable for widespread use. As the monkeypox situation evolves, SFDPH remains committed to exploring all options to protect San Franciscans.”
The ACAM2000 vaccine is no longer routinely given because it “has a higher risk of serious side effects, including hospitalization and death, than most other vaccines,” Sanchez stated.
Matt Hartwig, senior director of media relations for Emergent Solutions, the manufacturer of ACAM2000, told KRON4 that “ACAM2000 is not indicated for the treatment of monkeypox in the US or any other jurisdiction.
ACAM2000 isn’t dosing you with cowpox, the FDA website says it is dosing you with something similar to smallpox and cowpox called vaccinia virus. It also says the recently vaccinated can spread the vaccinia virus to others around them while their immune system is learning how to fight it and build an imune response. Also, 1 out of every 175 people dosed with the ACAM2000 vaccine will end up getting myocarditis or pericarditis. Sound familiar?
This is what the above FDA link says can happen just to people in the vicinity of someone vaccinated with ACAM2000-
“Serious health problems, including those that are life-threatening, can also occur in unvaccinated people who are accidentally infected by someone who has recently received the vaccine. In particular, unvaccinated people who are pregnant, or have problems with their heart or immune system, or have skin problems like eczema, dermatitis, psoriasis, and have close contact with a vaccine recipient are at an increased risk for serious problems if they become infected with the vaccine virus, either by being vaccinated, or by being in close contact with a person who was vaccinated.”